Abella, Michael B.
HRN: 23-74-90 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2026
06/05/2026
IV
650mg
Q6
Urti
Checking Initial Appropriateness
06/05/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/05/2026
06/12/2026
PO
4.5ml
Q8hrs
Amoebiasis
Checking Final Appropriateness